CD4 and AIDS: The recovery of the CD4/CD8 ratio bears significant clinical relevance, and research has demonstrated that patients with a low ratio are characterized by altered T cell subsets and heightened CD8+ T cell activation, which is linked to the overall extent of SARS-CoV-2–specific T cell responses and an elevated risk of non–AIDS-related morbidity and mortality [7-10].